Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Perioperative Respiratory Adverse Events in Children
ChiCTR2500102714Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial Maternal and Child Health Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in respiratory complication (2 arms), sponsored by Sichuan Provincial Maternal and Child Health Hospital. Primary endpoint: Incidence of respiratory adverse events. Planned start May 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
respiratory complication
Beyond the preview
Go deeper on ChiCTR2500102714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102714.